European Neuropsychopharmacology

Article	Citations
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	327
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility	284
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	104
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism	87
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	76
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	68
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	65
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	56
P.0224 Dosing regimen overview of treatment-resistant depression patients treated with esketamine: eskale study interim analysis	56
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	55
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	51
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	50
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	48
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	46
83. DAMAGING RARE CODING VARIANTS IDENTIFIED BY EXOME SEQUENCING ARE ASSOCIATED WITH REDUCED COGNITIVE FUNCTION IN SCHIZOPHRENIA	46
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	46
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	45
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	44
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	41
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	40
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	40
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	40
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	40
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	38
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	38

P.0016 Concomitant drug abuse in patients on methadone maintenance treatment	37
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	37
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	36
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	35
W13. CLINICAL VALUE OF DIAGNOSTIC WHOLE GENOME/EXOME SEQUENCING IN FAMILIAL AUTISM SPECTRUM DISORDER	33
TU90. STUDY OF GENETIC POLYMORPHISM AND DNA METHYLATION IN TUMOR NECROSIS FACTOR- ALPHA (TNF-Α) AND TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 (TM6SF2) IN ALCOHOL INDUCED LIVER CIRRHOSIS	33
W14. GENETIC CLUSTERING OF CO-OCCURRING SYMPTOMS IN PEOPLE WITH AUTISM: A MULTIVARIATE GENETIC VARIANCE ANALYSIS OF GENETIC RELATIONSHIP MATRICES IN THE SPARK SAMPLE	32
ASSESSING THE EFFECTS OF RARE COPY NUMBER VARIANTS ON PSYCHIATRIC SYMPTOMS AND COGNITIVE ABILITY IN ∼1M INDIVIDUALS	32
PHENOME-WIDE GENETIC CORRELATION AND CAUSALITY OF COVID-19 SEVERITY HIGHLIGHTS OVERLAP WITH SUBSTANCE-USE TRAITS	32
Society Calendar	32
6. CONTRIBUTION OF COPY NUMBER VARIANTS TO SCHIZOPHRENIA IN EAST ASIAN POPULATIONS	31
38. LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS	29
23. MASSIVELY PARALLEL, IN VIVO PROFILING OF MDD SNP EFFECTS ON TRANSCRIPTION ACROSS AGE, SEX, AND CELL TYPE	29
P.0190 Epigenetic mechanisms underlying the stress-induced activation of serum/glucocorticoid regulated kinase 1	29
P.0235 Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors	28
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	28
P.0234 Optogenetic shift of mesolimbic dopamine to tonic pattern reduces reward-seeking behavior	28
P.0254 TRPC4/5 inhibition reverses both stress-induced excessive aversion processing and attenuated reward processing in mice	27
P.0247 Assessment of sexual behavior of taar2 and taar5 knockout mice	27
P.0262 Self-directed virtual care: a review of the evidence for current digital therapeutic methods in adult mental health patients	27
P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis	26
P.0260 Optimising a human induced pluripotent stem cell system to model the effects of il-6 on early neurodevelopment	26
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	26
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	24
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	24
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	24
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	23
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	23
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	23
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	23
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	22
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	22
P.0487 The impact of psychopathy, temperament and character dimensions of personality on crimınal recidivism in patients with schizophrenia	21
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	21
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	20
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	20
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	20
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	19
P.0323 History of abuse and post traumatic stress disorder in patients admitted to an addictive disorders day hospital	19
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	19
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	19
P.0325 Corneal endothelial morphology and thickness changes in children with attention-deficit hyperactivity disorder	19
P.0564 Active suicidal ideation one year after the beginning of COVID-19 pandemic in a large spanish sample: risk and protective factors	19
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	19
P.0690 Transdifferentiation of human monocytes into neuronal-like cells in patients with depression	19
P.0669 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19–related trauma	18
P.0426 Proof-of-concept study testing SOM3355 for the treatment of chorea symptoms in Huntington's disease	18
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	17
P.0675 Inhibitory control in therapy resistant patients with major depressive disorder	17
P.0665 Reward processing differences between Obsessive-compulsive disorder and pathological gambling	17

THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	17
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	17
P.0511 The role of sex steroids and serotonin brain dynamics in perinatal mental health	17
P.0565 Calcium salt of N-(5-hydroxynicotinoyl)-L-glutamic acid weakens depressive-like behavior and Parkinsonian syndrome in experiment on rodents	16
P.0697 Exposure to an enriched environment shortens the onset of venlafaxine response which correlate with the remodeling of hippocampal parvalbumin interneurons	16
P.0632 The added value of cognitive behavioral therapy on quality of life in combination with pharmacotherapy in adults with ADHD	16
P.0663 Zebrafish model : study of KCNB1 in developmental and epileptic encephalopathies	16
ECNP Calendar of Meetings	16
P.0735 Functional impacts function - beyond organic symptoms in autoimmune encephalitis	15
P.0705 Antidepressant response prediction by early response, prefrontal theta cordance in rapid-eye movement sleep and ABCB1 genotype	15
Editorial Board	15
P.0753 Pharmacotherapy, treatment satisfaction and funcional impact among fibromyalgia patients: characterization of a Portuguese sample	15
Stress, mental disorder and ketamine as a novel, rapid acting treatment	14
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	14
Regulatory considerations in drug development for autism spectrum disorders	14
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	14
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	14
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies	14
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	14
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	14
Opioid use and misuse in Europe: COVID-19 new challenges?	14
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	14
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	14
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial	14
TH60. POLYGENIC MODELS OF COMORBIDITY AND PLEIOTROPY IN PSYCHIATRY IN A HIGHLY COMORBID COHORT	13
P.0059 Self-reported suicide attempts in the general population and association with alcohol consumption in Latvia in 2010-2018	13
Social Stress in Bipolar Disorder	13
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	13
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	13
P.0062 Role of stress history in the development of a depressive-like phenotype in elderly in rats exposed to repeated social defeat	13
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	13
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	13
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	13
TH82. NOVEL DISEASE ASSOCIATIONS WITH SCHIZOPHRENIA GENETIC RISK REVEALED IN ∼400,000 UK BIOBANK PARTICIPANTS	13
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	13
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	13
P.0126 Involvement of the snare complex SNAP-25 and stx1a polymorphisms in sarcopenia	12
PRS PREDICTION BEYOND FAMILY HISTORY	12
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	12
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	12
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	12
TU83. COMPARING GENE EXPRESSION CHANGES IN BLOOD AND BRAIN OF SCHIZOPHRENIA	12
P.0075 Sex differences in anxiolytic and antidepressant response following subacute drug treatment: the effect of the oestrous cycle	12
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	12
W31. USING NEURAL NETWORKS TO CREATE A POLYGENIC RISK SCORE OF MAJOR DEPRESSIVE DISORDER	12
P.0112 Evaluation of circadian rhythm parameters and NR1D1 single nucleotide polymorphism relationship to predict lithium response in bipolar disorder	12
W5. NUTRITIONAL BIOMARKERS IN PREGNANCY AND NEURODEVELOPMENTAL OUTCOMES IN OFFSPRING – A MENDELIAN RANDOMIZATION STUDY IN THE NORWEGIAN MOTHER, FATHER AND CHILD COHORT STUDY (MOBA)	12
W40. MEASURING 100 PERSONALITY TRAITS AND 9 COGNITIVE DOMAINS AT BIOBANK SCALE UNDER 1 HOUR – OPPORTUNITIES FOR PSYCHIATRIC GENOMICS	12
W79. METHYLATION AND BRAIN STRUCTURE IN SCHIZOPHRENIA: ANALYSIS OF THE ROLE OF COMT AND BDNF GENES	12
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	11
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	11
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	11
Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents	11
Number needed to treat and number needed to harm: What are they good for?	11
TH4. A CAUSAL ROLE FOR ATTENTION DEFICIT/ HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION	11
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	11
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	11
ECNP Calendar of Meetings	11
P.0713 Effectiveness and safety of vortioxetine in real-world clinical practice in China: results from the prospective RELIEVE China study	11
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	11
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	11
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	11
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	11
P.0747 The CD45+ blood cells alpha-synuclein concentration in synucleinopathies	11
P.0278 Structural brain abnormalities associated with cognitive impairments in bipolar disorder	10
21. DISSECTING THE PRENATAL ORIGINS OF PSYCHIATRIC DISORDERS USING SEX-BIASED MQTL IN THE PLACENTA	10
47. GENE DISCOVERY FROM EXOME SEQUENCING IN AUTISM AND COMPARISON TO DEVELOPMENTAL DELAY AND SCHIZOPHRENIA	10
55. MULTI-MODAL EVIDENCE THAT PANDEMIC INFLUENZA INFLUENCES SCHIZOPHRENIA RISK	10
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	10
P.0798 Acute peritraumatic distress predicts post-traumatic stress disorder at 6 months in patients with bipolar disorder followed during the COVID-19 pandemic	10
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	10
28. ESTIMATING THE GENETIC RELATIONSHIP BETWEEN PSYCHIATRIC DISORDERS AND CARDIOMETABOLIC TRAITS ASSESSED IN A SINGLE NATIONAL COHORT REPRESENTING DENMARK USING MULTIPLE METHODS	10
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	10
TU30. THE INTERACTION BETWEEN POLYGENIC LIABILITY AND VARYING STRESS LEVELS IN THE DEVELOPMENT OF MAJOR DEPRESSION: A LIFELINES COVID-19 PANDEMIC STUDY	10
P.0172 Deciphering the role of MIR-137 targetome in schizophrenia: temporal profiling and comorbidity with psychiatric disorders	10
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	10
GENETIC CHARACTERIZATION OF NEURODEVELOPMENTAL DISORDERS IN AFRICAN POPULATIONS: THE NEURODEV TRIO PILOT	10
W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	10
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	10
TU46. ASSOCIATION OF THE RS1031381 POLYMORPHIC VARIANT IN THE NCAPD3 GENE WITH PSYCHODIAGNOSTIC TRAITS (16 PF CATTELL'S QUESTIONNAIRE) IN RUSSIAN STUDENTS	10

W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	10
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	9
P.0631 Functional connectivity of basal ganglia nuclei in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile	9
P.0182 Cytomegalovirus infection and IQ in adolescents with early-onset psychosis	9
P.0438 Saccadik eye movements in simple and complex visual environments differenciate mild cognitive impairment: preliminary clinical results	9
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	9
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	9
P.0673 Specificity of neurocognitive impairment in patients with schizophrenia and endogenous depression	9
P.0364 Neurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers	9
P.0522 Accessing electroconvulsive therapy: description and factors associated with variation of utilization in france in 2019	9
P.0358 Synergistic anticonvulsant effect of carbamazepine and mono-/bicyclic terpenoids on pentylenetetrazole-induced seizures	9
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	9
P.0365 Associations between abnormal brain function during emotion processing and lifetime disease course in major depressive disorder	9
P.0477 Antipsychotic treatment and risk of discontinuation of cardiometabolic drugs in schizophrenia	9
P.0528 Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose	9
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	8
Editorial Board	8
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	8
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	8
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	8
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	8
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	8
F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	8
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	8
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	8
Editorial Board	8
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	8
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up	8
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	8
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	8
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	8
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	8
W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	8
Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages  58–68]	8
P.0393 Interoception sensitivity and social ineraction in major depressive episode	8
P.0374 Use of cariprazine in first episode mania: the importance of the treat and the treatment	8
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	8
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	8
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	8
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	8
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	8
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	7
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C	7
As in cooking, so in medicine: Doses do matter	7
Prader Willi syndrome, its psychiatric implications and their possible biological basis	7
Disease continuum centered on Parkinson's disease	7
14. PROFILING NEUROEPIGENOMIC NETWORKS OF OPIOID USE DISORDER IN HUMAN ORBITOFRONTAL CORTEX	7
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data	7
P.0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis	7
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	7
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	7
Neuroscience-based nomenclature of psychotropics: Progress report	7
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses	7
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	7
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	7
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	7
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	7
DELETERIOUS “SHIFT” IN FUNCTIONAL PERFORMANCE EXPLAINS CLINICAL VARIABILITY IN RARE GENETIC NEURODEVELOPMENTAL PSYCHIATRIC DISORDERS	7
The effects of acute dopamine depletion on resting-state functional connectivity in healthy humans	7
F73. CLINICAL AND GENETIC TRAUMA-RELATED RISK FACTORS LEADING TO SUICIDE DEATH	7
There are no patients without comorbidity	7
Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients	7
The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years	7
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	7
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker	7
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	7
Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice	7
Assessing risk for bipolar disorder. Comments on ``Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study'' (Martin	7
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	7
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	7
Autoimmune encephalitis or autoimmune psychosis?	7
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	6
P.0114 Complement factor C4 and phenotypes in bipolar disorder	6
93. DEVELOPING A PHENOTYPE RISK SCORE FOR TIC DISORDERS IN A LARGE CLINICAL BIOBANK	6
63. LEVERAGING GWAS FOR INSOMNIA TO IDENTIFY NOVEL REGULATORS OF SLEEP	6
73. ACCOUNTING FOR FAMILY HISTORY AND AGE OF ONSET IMPROVES POWER IN GENOME-WIDE ASSOCIATION STUDIES	6
T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA	6
BASIC CONCEPTS IN PSYCHIATRIC GENETICS	6
94. AN INDUCED PLURIPOTENT STEM CELL (IPSC) RESOURCE FROM GENETICALLY ISOLATED FAMILIES WITH NEUROPSYCHIATRIC DISORDERS	6
W85. EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF THE UBACC QUESTIONNAIRE IN ASSESSING CAPACITY TO CONSENT IN DIVERSE AFRICAN POPULATIONS	6
81. PATTERNS OF BRAIN ASYMMETRY ASSOCIATED WITH POLYGENIC RISKS FOR AUTISM AND SCHIZOPHRENIA IMPLICATE LANGUAGE AND EXECUTIVE FUNCTIONS BUT NOT BRAIN MASCULINIZATION	6
20. CHROMATIN ACCESSIBILITY MAPPING REVEALS COMPOUND GENETIC EFFECTS AT A SCHIZOPHRENIA GWAS RISK LOCUS IMPAIRING NEURODEVELOPMENT AND SYNAPTIC FUNCTION IN HUMAN NEURONS	6
T56. NEONATAL BLOOD TRANSCRIPTOMICS REVEAL EXPRESSION SIGNATURES OF ADHD RISK	6
P.0251 Influence of the a2a antagonist kw6002 on dopaminergic system, motor functioning and neuroinflammation in a rodent model of parkinson's disease	6
DNA METHYLOME-WIDE ASSOCIATION STUDY OF POLYGENIC RISK SCORES FOR DEPRESSION IMPLICATING ANTIGEN PROCESSING AND IMMUNE RESPONSES	6
ECNP Calendar of Meetings	6
95. PSYCHIATRIC GENETIC COUNSELING IS ASSOCIATED WITH A DECREASE IN PSYCHIATRIC HOSPITALIZATION	6
49. INTEGRATION OF TRANSCRIPTOMIC AND PROTEOMIC DATA TO REFINE POLYGENIC-RISK INFORMED DRUG REPURPOSING CANDIDATES FOR PSYCHOSIS	6
P.0173 Cannabinoid receptor genes, cannabis use and brain activity in first-episode psychosis	6
P.0227 Integrated care with pharmacists in monitoring of ambulatory patients using lithium	6
P.0271 Association of polymorphic marker val158met of comt gene with depression in an open population 25-44 years: epidemiological study	6
Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis	6
P.0392 Care pathways for people with major depressive disorder	5
P.0909 Long-acting injectable risperidone vs paliperidone: cardiovascular and metabolic risk factors	5
P.0308 Safety and efficacy of alcohol hangover treatments	5